Annual report pursuant to Section 13 and 15(d)

13. Business Combinations (Details - Proforma)

v3.3.1.900
13. Business Combinations (Details - Proforma) - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Net Revenues $ 18,818,038 $ 58,568,565
Operating Expenses 67,507,045 48,632,498
Income (Loss) from operations (48,689,007) 9,936,067
Other income (expense) 431,215 (287,608)
Income (Loss) before income taxes (48,257,792) 9,648,459
Provision for income taxes (9,297,253) 4,727,745
Net income (loss) attributable to Rennova Health (38,960,539) 4,920,714
Preferred stock dividends 0 0
Net income (loss) attributable to Rennova Health common shareholders $ (38,960,539) $ 4,920,714
Net income (loss) per common share: Basic $ (2.93) $ 0.37
Net income (loss) per common share: Diluted $ (2.93) $ 0.36
Weighted average number of common shares outstanding during the period: Basic 13,299,637 13,296,716
Weighted average number of common shares outstanding during the period: Diluted 13,299,637 13,716,596
Pro Forma Adjustments [Member]    
Net Revenues $ 0 $ 0
Operating Expenses 0 0
Income (Loss) from operations 0 0
Other income (expense) 0 0
Income (Loss) before income taxes 0 0
Provision for income taxes 0 (2,532,555)
Net income (loss) attributable to Rennova Health 0 0
Preferred stock dividends (1,627,188) (5,010,300)
Net income (loss) attributable to Rennova Health common shareholders 1,627,188 5,010,300
Rennova Health, Inc. [Member]    
Net Revenues 18,393,038 57,927,820
Operating Expenses 62,626,045 42,272,826
Income (Loss) from operations (44,233,007) 15,654,994
Other income (expense) 474,215 (273,362)
Income (Loss) before income taxes (43,758,792) 15,381,632
Provision for income taxes (9,028,253) 7,561,300
Net income (loss) attributable to Rennova Health (34,730,539) 7,820,332
Preferred stock dividends 1,627,188 5,010,300
Net income (loss) attributable to Rennova Health common shareholders $ (36,357,727) $ 2,810,032
Net income (loss) per common share: Basic $ (2.93) $ 0.23
Net income (loss) per common share: Diluted $ (2.93) $ 0.22
Weighted average number of common shares outstanding during the period: Basic 12,423,294 12,247,978
Weighted average number of common shares outstanding during the period: Diluted 12,423,294 12,667,858
CollabRx, Inc. [Member]    
Net Revenues $ 425,000 $ 44,299
Operating Expenses 4,881,000 329,258
Income (Loss) from operations (4,456,000) (284,959)
Other income (expense) (43,000) 12,753
Income (Loss) before income taxes (4,499,000) (272,206)
Provision for income taxes (269,000) 0
Net income (loss) attributable to Rennova Health (4,230,000) (272,206)
Preferred stock dividends 0 0
Net income (loss) attributable to Rennova Health common shareholders $ (4,230,000) (272,206)
Clinlab, Inc. [Member]    
Net Revenues   98,446
Operating Expenses   94,414
Income (Loss) from operations   4,032
Other income (expense)   1
Income (Loss) before income taxes   4,033
Provision for income taxes   0
Net income (loss) attributable to Rennova Health   4,033
Preferred stock dividends   0
Net income (loss) attributable to Rennova Health common shareholders   4,033
Epinex Diagnostics Laboratories, Inc. [Member]    
Net Revenues   498,000
Operating Expenses   5,936,000
Income (Loss) from operations   (5,438,000)
Other income (expense)   (27,000)
Income (Loss) before income taxes   (5,465,000)
Provision for income taxes   (301,000)
Net income (loss) attributable to Rennova Health   (5,164,000)
Preferred stock dividends   0
Net income (loss) attributable to Rennova Health common shareholders   $ (5,164,000)